Eligible studies were retrieved from international databases up to December 2019. Studies with a relationship between the clinicopathological and prognostic value of CRC patients with BMI-1 expression were selected. The correlations in the random-effect model were evaluated using the hazard ratios (HRs), odds ratio (OR), and 95% confidence intervals (CIs).
A total of 9 studies comprising Asian cases (7 studies) and European cases (2 studies) covering 1,294 samples of CRC were included for this meta-analysis. The analysis suggested that in Asian cases, increased expression of BMI-1 was associated with poor overall survival (OS) and death free survival (DFS). While, In European populations, high expression of BMI-1 was associated with better OS. Also, overexpression of BMI-1 in the Asian population was associated with the tumor size, distant metastasis of, patient’s gender and age.
Results suggested that high expression of BMI-1 can be involved in the progression and invasion of CRC, and so its inhibitor-based therapies could be used to prevent the progression of CRC. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.